PharVision Advisers »

Textron shares owned by PharVision Advisers

Quarter-by-quarter ownership of Textron (TXT) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Textron

Tip: Access up to 7 years of quarterly data

All positions including Textron held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Textron by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $348k 4.1k 84.49

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Textron

Vanguard Group
BlackRock
State Street Corporation
Invesco
T. Rowe Price Investment Management
Robeco Investment Management
FMR
Geode Capital Management
LSV Asset Management
Victory Capital Management
AQR Capital Management
PRIMECAP Management Company
Jpmorgan Chase & Co
Brandes Investment Partners
Morgan Stanley

View all funds holding Textron